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Enzymes acting over glyceryl ethers are scarce in living cells, and consequently biocatalytic transformations
of these molecules are rare despite their interest for industrial chemistry. In this work, we have engineered
and immobilised a glycerol dehydrogenase from Bacillus stearothermophilus (BsGlyDH) to accept a battery
of alkyl/aryl glyceryl monoethers and catalyse their enantioselective oxidation to yield the corresponding 3-
alkoxy/aryloxy-1-hydroxyacetones. QM/MM computational studies decipher the key role of D123 in the
oxidation catalytic mechanism, and reveal that this enzyme is highly enantioselective towards S-isomers
(ee > 99%). Through structure-guided site-selective mutagenesis, we find that the mutation L252A
sculpts the active site to accommodate a productive configuration of 3-monoalkyl glycerols. This
mutation enhances the kcat 163-fold towards 3-ethoxypropan-1,2-diol, resulting in a specific activity
similar to the one found for the wild-type towards glycerol. Furthermore, we immobilised the L252A
variant to intensify the process, demonstrating the reusability and increasing the operational stability of
the resulting heterogeneous biocatalyst. Finally, we manage to integrate this immobilised enzyme into
a one-pot chemoenzymatic process to convert glycidol and ethanol into 3-ethoxy-1-hydroxyacetone
and (R)-3-ethoxypropan-1,2-diol, without affecting the oxidation activity. These results thus expand the
uses of engineered glycerol dehydrogenases in applied biocatalysis for the kinetic resolution of glycerol
ethers and the manufacturing of substituted hydroxyacetones.Introduction
Enzymes acting over glyceryl ether substrates are scarce in cell
metabolisms. Among the low diversity of biochemical reactions
involving glyceryl ethers, we highlight lignin biosynthesis,1 theSelectivas, Instituto de Śıntesis Qúımica y
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f Chemistry 2020metabolic synthesis of ether lipids2 and plasmalogens3–5 that
play important physiological roles.6
Despite the low abundance of glycerol derived alkyl ethers in
nature, these molecules are enormously attractive for the
chemical industry to manufacture both commodities7 (i.e. fuels
and solvents)8 and specialised products (i.e. cosmetics and
drugs).9–11 In particular, monoalkylated glycerol ethers are
considered among the most promising targets to valorise the
surplus of glycerol from biorenery activities.12–14 The chemical
structure of many approved and commercial drugs incorporates
a glycerol skeleton with at least one alkoxy or aryloxy substituent
(Scheme 1A). Some of these drugs are administered as pure
enantiomers which encourages medical chemists to develop
enantioselective synthetic schemes. Herein, biocatalysis bursts
as a key enabling technology in chemical manufacturing due to
the exquisite regio- and enantioselectivity of enzymes.
In the last decade, the pharmaceutical industry is success-
fully integrating more biocatalytic steps in their drug synthetic
processes; new enzyme routes for the manufacturing of sita-
gliptin15 and islatravir16 illustrate this trend.
Synthesis of monoalkyl/aryl glycerols have been attained
through many different chemical methodologies, including
both stoichiometric and catalytic ones.17 Recently, Leal-DuasoChem. Sci., 2020, 11, 12009–12020 | 12009
Scheme 1 (A) Drugs containing alkyl/aryl-glycerol scaffolds (in blue).
(B) Retrosynthesis pathway towards enantiopure alkyl/aryl glyceryl
monoethers and substituted hydroxyketones from renewable starting
materials. (C). Two-step chemo-enzymatic route to access (R)-3-
(alkoxy/aryloxy)propan-1,2-diol and their corresponding 3-alkoxy/
aryloxy-1-hydroxyacetone.


































































































View Article Onlineet al. reported a straightforward methodology to synthesise
glyceryl monoethers from glycidol and several alcohols using
KOH as catalyst (Scheme 1B).18 Nevertheless, the reaction yields
a racemic product that makes the isolation of the target enan-
tiomer a non-viable task for practical purposes. To access one of
the enantiomers, a kinetic resolution is demanded. In this
context, lipases19,20 are efficient catalysts to selectively acetylate
only one enantiomer of glycerol derivatives, so the unreactive
enantiomer is easily puried. Although alcohol dehydrogenases
have also been applied for kinetic resolution of sec-alcohols,21
they have never been applied with glycerol derivatives. The
enantioselective oxidation of monoalkyl glycerols will provide
a double opportunity to access enantiomerically pure alkyl
glycerols as building blocks for drug synthesis andmanufacture
of 3-alkoxy/aryloxy-1-hydroxyacetone as a new family of bio-
based solvents to be explored (Scheme 1B).8 Moreover, enzy-
matic synthesis of these hydroxyacetone monoethers is
unprecedented but highly interesting as key building blocks for
the biosynthesis of non-natural deoxysugars22 and cosmetics.23
The best candidates to catalyse such selective oxidation
would be the glycerol dehydrogenases (GlyDH) due to their
natural substrate specicity. Biotechnological applications of
these enzymes however are mainly limited to the whole cell
production of dihydroxyacetone24 and valuable diols through
metabolic engineering.25 Besides, this family of enzymes has
also been widely applied in biosensing as the active phase of
glycerol sensors.26 Nevertheless, their substrate scope is12010 | Chem. Sci., 2020, 11, 12009–12020extremely narrow, restricted mainly to glycerol in the oxidation
direction. Among the few exceptions, the wild-type GlyDHs from
Klebsiella genus are able to oxidise a substrate bulkier than
glycerol, and that promiscuity increases when replacing the
catalytic Zn2+ by other divalent metals.27 Remarkably, the GlyDH
from Enterobacter (Klebsiella) aerogenes oxidises the R-phenyl-
glycol to 2-hydroxyacetophenone in a regio- and enantiose-
lective manner.28
Hundreds of examples endorse the improvement of enzyme
properties (activity, stability and selectivity) and the widening of
their substrate scope through protein engineering. As safe path
for enzyme optimization, the scientic community exploits,
either separately or synergistically, random and extensive
mutagenesis campaigns through directed evolution29 and
minimalist mutations through site-directed mutagenesis
guided by structural knowledge.22,30,31 In the particular case of
GlyDH, one of the few documented successes is the combina-
tion of DNA-shuffling and site-directed mutagenesis to expand
the GlyDH substrate scope to other diols. This variant was 2.6
times more active towards 1,3-butanediol than the wild-type.32
Despite these efforts, GlyDHs have never been challenged
against bulkier substrates like glycerol monoethers.27
Besides re-shaping the active site of enzymes to improve
their intrinsic functional features, the engineering journey
must include the enzyme immobilisation to fabricate robust
biocatalysts that are easily to separate from the reaction media
and readily to integrate into different bioreactor congurations.
In the last years, the immobilization of engineered enzyme
variants has allowed their application under industrially rele-
vant conditions.16,33–35 To that aim, selective immobilization
protocols that assure the activity and increase the stability of the
enzymes upon the attachment to the solid carrier are pretended.
In this work, we rationally engineer GlyDH from Bacillus
stearothermophilus (Wt-BsGlyDH) to selectively oxidise alkyl/aryl
glycerols to 3-alkoxy/aryloxy-1-hydroxyacetones. Before starting
the engineering campaign, we shined light on the uncertainties
found in its catalytic mechanism. Besides explaining how this
enzyme positions the substrate into its active site, Quantum
Mechanics/Molecular Mechanics (QM/MM) computational
studies also reveal its enantiopreference towards the S-isomer of
the alkylated glycerol. This information was instrumental to
further design mutations at the active site that allowed the
enzyme accommodating bulkier glycerol monoethers. From the
molecular design, we walked towards the process development
by immobilizing the most active engineered variant. The
resulting heterogeneous biocatalyst eases the product separa-
tion and increases the enzyme operational stability. Finally, the
heterogeneous biocatalyst herein presented was coupled to
a one-pot sequential chemo-enzymatic process to synthesise
enantiopure glycerol monoethers from glycidol and ethanol
without intermediate purication steps (Scheme 1C).
Materials and methods
Chemicals
Glycerol, hydrogen peroxide, dihydroxyacetone (DHA), avin-
adenine-dinucleotide sodium salt (FAD+), acetic anhydrideThis journal is © The Royal Society of Chemistry 2020


































































































View Article Onlineand N-methylimidazole, kanamycin sulfate from Streptomyces
kanamyceticus and ampicillin, catalase from bovine liver (Hl-
CAT) were acquired from Sigma-Aldrich (St. Louis, IL, USA).
Nicotinamide adenine dinucleotide reduced disodium salt
(NADH), nicotinamide adenine dinucleotide sodium salt
(NAD+) and isopropyl b-D-thiogalactopyranoside (IPTG), were
purchased from GERBU Biotechnik GmbH (Wieblingen, Ger-
many). Glyceryl monoethers and diethers were synthesised as
previously described (Table S1‡).18,36 Cobalt-activated agarose
microbeads 4BCL (AG-Co2+) (particle size; 50–15 mm, pore size;
112 nm and 15 mmol of Co2+ per g carrier) were purchased from
ABT technologies (Madrid, Spain). Precision plus protein™
standards, micro Bio-spin™ chromatographic columns and
Bradford reagent were acquired from BIORAD. All other
reagents and solvents were analytical grade or superior.Methods
Site-directed mutagenesis to create the variants of GlyDH. A
site-directed mutagenesis protocol was used to construct seven
GlyDH mutants (tree single mutants, V131A, Y142A, L252A;
three double mutants, V131A/L252A, V131A/Y142A, Y142A/
L252A; and one triple mutant, V131A/Y142A/L252A). These
mutants were constructed by using the Wt-GlyDH gene as
template. The genetic construct pET28b(+)_his-glydh was
developed in a previous work.37 Briey, to introduce the desired
amino acid change, the corresponding pairs of oligonucleotides
(Table S2‡) were used as primers in the polymerase chain
reaction (PCR) using the above mentioned construct as
template and high delity NZYProof DNA polymerase. The
product of the PCR was digested with DpnI that exclusively
restricts methylated DNA. E. coli DH5a cells were transformed
directly with the digestion product. The plasmids that harbour
the mutated GlyDH genes were identied by sequencing and
then transformed into E. coli BL21(DE3) cells to express the
corresponding enzyme variants.
Cloning of his-tagged water forming NADH oxidase variants
from Lactobacillus pentosus (Lp-NOX). The gene described by
Nowak et al.38 was optimised for E. coli codon usage and syn-
thesised by Genscript Biotech (Piscataway, NJ, USA). The
synthetic gen was cloned into pET28b(+) using NdeI and XhoI
restriction sites. DNA isolation, plasmid purication, restriction
analysis, plasmid construction and DNA sequencing were
carried out by standard methods.39
Bacterial strains and growth conditions. Glycerol dehydro-
genase from Bacillus Stearothermophilus (BsGlyDH), NADH
oxidases from Thermus thermophilus (Tt-NOX) and Lactobacillus
pentosus (Lp-NOX) were overexpressed in E. coli BL21 cells as
previously reported.37,40 Briey, 1 mL of an overnight culture of
E. coli BL21(DE3) harboring each plasmid was used to inoculate
50 mL of Luria-Bertain (LB) medium containing the corre-
sponding antibiotic; kanamycin (nal concentration 30 mg
mL1) was used for all enzymes but Tt-NOX that required
ampicillin (nal concentration 50 mg mL1). The resulting
culture was aerobically incubated at 37 C with orbital shaking
at 250 rpm until the OD 600 nm reached 0.6. Aerwards, the
culture was induced with 1 mM IPTG. All enzymes were inducedThis journal is © The Royal Society of Chemistry 2020for 3 h at 37 C but Lp-NOX was incubated at 21 C for 18 h. Aer
the induction time, cells were harvested by centrifugation at
4211 g for 30 min at 4 C. Supernatants were discarded and the
pellet was resuspended in 5 mL of 25 mM sodium phosphate
buffer solution at pH 7. Cells were broken by sonication using
a Sonoplus Serie 4200, Bandelin at 20% amplitude (5 s ON/5 s
OFF) for 20 min at 4 C. The suspension was then centrifuged at
10 528 g for 30 min at 4 C and the pellet was discarded. The
supernatant containing cell extracts with the His-tagged
proteins (except Tt-NOX) were collected and employed for
further purication and/or immobilization.
Purication of enzymes. The purication of GlyDH and the
variants, as well as the Lp-NOX were done according the
following procedure: 10 volumes of crude cell extract containing
the his-tagged enzymes were mixed with 1 volume of AG-Co2+
microbeads and incubated under orbital shaking for 1 to 2 h at
4 C. Later, the suspension was ltered and the microbeads
containing the enzyme were washed with 5 volumes of 25 mM
phosphate buffer at pH 7. Aerwards, enzymes were eluted by
the addition of 5 volumes of 300 mM imidazole in sodium
phosphate buffer 25 mM pH 7 and incubated for 1 h at 4 C with
orbital shaking. The eluted protein was subjected to dialysis to
remove the imidazole. Finally, SDS-PAGE and Bradford protein
assay41 were carried out aer each production to determine the
purity, concentration and specic activity of the enzymes
(Fig. S1‡). Tt-NOX was puried as previously described through
thermal shock.40
Enzymatic activity measurements. Enzyme activities were
spectrophotometrically measured in transparent 96-well
microplates, employing a Microplate Reader Epoch 2, BioTek®
with the soware Gen5.
GlyDH activity (colorimetric assay). (1a, rac-1b, rac-1c, rac-1d,
rac-1e, rac-1f, rac-1g, rac-1h, 1b-bis and 1c-bis) and 1 mM NAD+
in sodium phosphate or sodium bicarbonate buffer 100 mM at
pH 7 or 9, respectively; were incubated with 5 mL of enzymatic
solution or suspension at 30 C. The increase of the absorbance
wasmonitored at 340 nm. One unit of activity was dened as the
amount of enzyme that was required to reduce 1 mmol of NAD+
per minute at the assayed conditions.
NOX activity (colorimetric assay). 200 mL of a reaction mixture
containing 0.2 mM NADH and 150 mM FAD+ in phosphate
buffer pH 7 were incubated with 5 mL of enzymatic solution or
suspension at 30 C. The decrease in the absorbance was
monitored at 340 nm. One unit of activity was dened as the
amount of enzyme that was required to oxidise 1 mmol of NADH
per minute at the assayed conditions.
CAT activity (colorimetric assay). The activity was determined
by recording the decrease in the absorbance at 240 nm of 200 mL
of a reaction mixture containing 35 mM hydrogen peroxide in
sodium phosphate buffer 100 mM pH 7 at 30 C. The reaction
was initiated by adding 5 mL of the enzymatic solution or
suspension to the reaction mixture. One unit of CAT activity was
dened as the amount of enzyme required for the dispropor-
tionation of one mmol of hydrogen peroxide per minute at the
assessed conditions.
Co-immobilization of Lp-NOX and BsGlyDH-L252A on AG-
Co2+. The enzymes were immobilised by mixing 10 volumes ofChem. Sci., 2020, 11, 12009–12020 | 12011


































































































View Article Onlinecrude cell extract containing the His-tagged protein with 1
volume of AG-Co2+ microbeads and incubated under orbital
shaking for 1 to 2 h at 4 C. Later, the suspension was ltered
and the microbeads containing the enzyme were washed with 5
volumes of 25 mM phosphate buffer at pH 7. The immobilised
biocatalyst was stored at 4 C. The co-immobilised biocatalyst
comprising GlyDH-L252A and Lp-NOX where prepared
following the former methodology but sequentially immobiliz-
ing one by one enzyme, starting by the GlyDH-L252A followed by
the Lp-NOX.
Oxidation of glyceryl ethers by GlyDH-L252A biocatalysts.
For rac-1c, immobilised GlyDH-L252A on AG-Co2+, Tt-NOX and
Hl-CAT were mixed with 0.3–50 mL of 25–100 mM substrate, as
indicated, 1 mM NAD+, 150 mM FAD+ in 100 mM sodium
phosphate buffer at pH 7. For rac-1h, co-immobilised GlyDH-
L252A and Lp-NOX on AG-Co2+ was mixed with 1 mL of 2 mM
substrate, 4 mM NAD+ in 100 mM sodium phosphate buffer at
pH 7. Both mixtures were incubated at 30 C in a vertical
rotating shaker at 40 rpm. Reaction curse was monitored by
withdrawing samples at periodic intervals that were analysed by
chromatographic methods.
Chemo-enzymatic synthesis. 0.87 mmol of KOH were solved
in 3.81 mL of dried absolute ethanol (15 : 1 mol ratio in respect
to glycidol). Then the mixture was heated at 65 C and 0.3 mL of
rac-glycidol (4.35 mmol) were added dropwise for 15 min. Aer
2 hours, when rac-glycidol has completely been converted to rac-
1c, the temperature was cooled down to 25 C, KOH neutralised
with 0.3 M HCl and the salts ltered off.
Heterogeneous biocatalyst GlyDH-L252A co-immobilised
with Lp-NOX on AG-Co2+ (100 mg biocatalyst) was placed
inside a 1.5 mL Bio-spin™ chromatographic column. Then, 500
mL of reaction mixture consisted in 20 mM of the rac-1c
substrate (pure, raw from chemosynthesis with ethanol and raw
from chemosynthesis without ethanol), 1 mM NAD+, 150 mM
FAD+ in 100 mM sodium phosphate buffer at pH 8 and were
added and incubated a 30 C in a vertical rotating shaker at
40 rpm. Aer 24 and 48 h, columns were spin down and the
recovered reaction mixtures were analysed as described in the
chromatographic methods.
Operational stability of biocatalyst. Recycling of heteroge-
neous biocatalyst BsGlyDH-L252A immobilised on AG-Co2+
(144 mU, 100 mg biocatalyst) was determined by placing the
biocatalyst inside a 1.5 mL Bio-spin™ chromatographic column
with 300 mL of reaction mixture consisted in 25 mM of rac-1c,
1 mM NAD+, 150 mM FAD+, 720 mU of soluble Tt-NOX and
36 000 mU of Hl-CAT in 100 mM sodium phosphate buffer at
pH 7 and incubated at 30 C in a vertical rotating shaker at
40 rpm. Aer each reaction cycle (24 h), columns were spin
down and washed one time with one volume of 25 mM sodium
phosphate buffer at pH 7 before starting the next reaction cycle.
Recovered reaction mixtures were analysed as described in the
chromatographic methods.
Chromatographic methods
Gas chromatography (GC). Prior GC analysis, samples were
derivatised as described elsewhere.42 Briey, 30 mL of aqueous
reaction simple were placed in a 1.5 mL Eppendorf tube, fol-
lowed by the addition of 30 mL of N-methylimidazole and 225 mL12012 | Chem. Sci., 2020, 11, 12009–12020of acetic anhydride and incubated by 10 min at room temper-
ature. Aerwards, 300 mL of distilled water was added and
allowed to cool down. Later, liquid–liquid extraction of acety-
lated compounds was done by the addition of 300 mL of
dichloromethane containing 2 mM eicosane as external stan-
dard discarding the aqueous phase. 30–50 mg of anhydrous
MgSO4 were added to dry samples before GC analysis. Gas
chromatography analyses were carried out in a Hewlett Packard
7890 Series II gas chromatograph using a column of phenyl
silicone 5.5% (Zebron ZB-5HT Inferno 30 m  0.25 mm  0.25
mm), helium as carrier gas, and equipped with a ame ioniza-
tion detector (FID). Injector at 250 C, FID at 280 C. Separation
of 1c derivatives were done by the following temperature
program: initial temperature at 60 C, maintained 2 min, ramp
to 240 C at a rate of 20 C min1 and nally maintained 2 min.
Retention times for acetylated compounds were: rac-1c: 7.88 min,
3-ethoxy-1-hydroxyacetone: 6.75 min and eicosane: 12.2 min. The
samples were additionally analysed using a Hewlett Packard 6890
Series II Gas chromatograph using a column of phenyl silicone
5.5% (Zebron ZB-5HT Inferno 30 m  0.25 mm  0.25 mm),
coupled to an Agilent 5973 inert Mass Spectrometer with Elec-
tronic Impact ionization.
Chiral high performance liquid chromatography (HPLC).
Before their analysis, samples were ltered and diluted in iso-
propanol as required. Prepared samples were analysed by HPLC
(Waters 2690) with a Lux 5 m cellulose-1 chiral column (250 mm
4.60 mm) Phenomenex, equipped with a PDA detector at 270 nm.
Analytes were eluted at 1 mL min1 constant ow with a normal
mobile phase composed by hexane/isopropanol (85 : 15).43 Reten-
tion times were: R-1h: 11.9 min, S-1h: 23.4 min and 1-phenoxy-3-
hydroxyacetone (2h): 5.4 min.
QM/MM computational methods. All the systems, wild-type
BsGlyDH with glycerol, S-1c and R-1c enantiomers, BsGlyDH-
L252A mutant with glycerol, S-1c and R-1c enantiomers and
BsGlyDH-D123N mutant with glycerol were solvated by a box of
water molecules and were neutralised adding counterions by
tLEaP module44 from AmberTools17 package.45 Preliminary
minimizations and molecular mechanics (MM) and molecular
dynamics (MD) simulations were performed in order to equili-
brate the systems with the AMBER ff14SB and TIP3P force elds
to describe the protein and water molecules, respectively.
Exploration of the QM/MM potential energy surfaces (PESs),
and localization and characterization of transition state (TS)
structures were carried out prior to the generation of the QM/
MM free energy surfaces generated in terms of potentials of
mean force (PMFs) at M06-2X(6-31+G(d,p)):PM3/AMBER/TIP3P
PMFs level of theory, including zero point energy (ZPE) correc-
tions. Full computational details are given in the ESI.‡
Results and discussion
Engineering of GlyDH and mechanistic insights
Inspired by previous works,46,47 we sketched a retrosynthetic
pathway to access enantiopure alkyl/aryl glyceryl monoethers
starting from inexpensive epoxides such as glycidol, which can
be readily synthesized from glycerol (Scheme 1B). Once racemic
glycerol ethers are chemically synthesized under basicThis journal is © The Royal Society of Chemistry 2020
Fig. 2 Proposed glycerol oxidation mechanisms for Wt-BsGlyDH. (1)
Proton transfer through water molecule. (2) Proton transfer through
the Asp123. R: glycerol/TS: transition state for mechanism 1/TS1 and
TS2 transition state for mechanism 2/I1: alkoxide intermediate/P:
dihydroxyacetone.


































































































View Article Onlineconditions,18 we propose their sequential enzymatic regio- and
enantioselective oxidation. Unfortunately, none oxidoreductase
has been described to efficiently conduct the selective oxidation
towards this type of monoglyceryl ethers. GlyDH is one of the
potential enzymes to catalyse that reaction, since it efficiently
oxidises glycerol to dihydroxyacetone.48 Nevertheless, its oxida-
tion activity is practically restricted to its natural substrate:
glycerol. To go beyond glycerol, we tested two GlyDHs from
different bacterial sources for the selective oxidation of mono-
alkylglycerols. We detected some oxidative activity towards
a battery of pure monoalkylglyceryl ethers using both wild-type
GlyDH from Cellulomonas sp. (CsGlyDH) and from Bacillus
stearothermophilus (BsGlyDH) (Table S3‡). These results agree
with the residual activity previously reported for CsGlyDH
towards 1b.49 Remarkably, the relative activity of the enzyme
from Bacillus was higher than the one from Cellulomonas
towards a wider scope of glycerol ethers. These insights moti-
vated us to engineer BsGlyDH through a structure-guided
approach.
The reported crystal structures (PDB ID: 1JQ5 and 1JQA)48 of
BsGlyDH show that O1 and O2 atoms of glycerol are coordi-
nated to the catalytic Zn2+ atom, which explains the exquisite
specicity of this enzyme for 1,2-diols as substrates. In contrast,
the O3 seems to be neutral in the catalytic mechanism but it is
conned into the cavity formed by V131, Y142 and L252, sup-
porting the fact, that glycerol is the preferential substrate
(Fig. 1). Despite the available structural information, the precise
catalytic mechanism of hydride transfer from C2 atom ofFig. 1 Overlap of crystal structures of GlyDH from Bacillus stear-
othermophilus binding its native substrate glycerol (pink sticks/PDB ID:
1JQA), the catalytic Zn2+ (blue sphere/PDB ID: 1JQ5) and the NAD+
(yellow sticks/PDB ID: 1JQ5). Residues V131, Y142 and L252 that form
the substrate cavity are highlighted as green spheres. Black dash line
represents the hydride transfer fromC2 atomof glycerol to C4 atomof
NAD+ (see Fig. 2). Yellow dash lines represent the coordination of O1
and O2 atoms from glycerol with the Zn2+ atom.
This journal is © The Royal Society of Chemistry 2020glycerol to C4 atom in NAD+ remains unclear (Fig. 2). Then,
before sculpting the active site to accommodate bulkier
substituents in O3, we decided to explore the free energy
proles to unveil the BsGlyDH mechanism at atomistic level
(see ESI‡). In the literature, a water molecule is suggested to act as
a base to abstract the proton from the C2 hydroxyl group and form
the alkoxide intermediate to subsequently proceed with the
hydride transfer from C2 atom of glycerol to NAD+ cofactor.48
However, this mechanism has been demonstrated neither through
experimental nor computational evidences. There are other short-
chain alcohol dehydrogenases/reductases (SDRs) from Drosophila
melanogaster and Drosophila lebanonensis50 that contain highly
conserved active site residues (Ser and Tyr) that act as strong base
for the proton abstraction. Moreover, inmannitol 2-dehydrogenase
from Pseudomonas uorescens,51 a Lys residue functions as the
catalytic base that facilitates hydride transfer to NAD+ by proton
abstraction from alcohol. Classical MD simulations of the fully
solvated substrate–enzyme complex keep the Zn2+ ion ve coordi-
nate complex, as in the initial X-ray structure of Ruzheinikov et al.,48
including the coordination to O2 atom. Nevertheless, two different
conformations of glycerol bound to the active center are identied
(Fig. 2 and S2–S4‡). In one conformation the proton from O2 atom
of glycerol establishes hydrogen bond interaction with a water
molecule while in the other conformation; this proton establishes
a hydrogen bondwith D123 residue. This fact led us to propose two
different reaction mechanisms (Fig. 2). Mechanism 1 involves the
proton transfer from O2 atom of glycerol to a water molecule fol-
lowed by a hydride transfer from C2 atom of glycerol to C4 atom of
NAD+ as proposed in the literature.48 Contrariwise, mechanism 2
leads to a proton transfer between the substrate and the acid
residue before the hydride transfer from glycerol to NAD+. To
decipher the most likely mechanism, we generated the full free
energy landscapes for the two proposed mechanisms by means of
multiscale QM/MM simulations. In particular, free energy surfaces
were computed for every chemical step as potentials of mean force
(PMFs) at M06-2X/6-31+G(d,p):PM3/MM level of theory (see ESI
Fig. S5 and S6‡).Chem. Sci., 2020, 11, 12009–12020 | 12013
Fig. 3 Specific activity of wild-type and several mutants of BsGlyDH
towards alkyl/acylglyceryl ethers. In all cases, reaction mixtures con-
sisted in 100 mM substrate, 1 mM NAD+ in 100 mM sodium phosphate
buffer at pH 7 at 30 C, 1b-bis and 1c-bis are the corresponding dia-
lkyl-ether with methyl and ethyl substituents, respectively.


































































































View Article OnlineAccording to the results, mechanism 1 can be discarded due
to the resulting overall high free energy barrier
(57.6 kcal mol1), indicating that water is unable to act as base
for the proton subtraction from the O2 hydroxyl group (for
further details see ESI, Fig. S5 and S6A‡). Furthermore, our
M06-2X/6-31+G(d,p):PM3/MM free energy surfaces and M06-2X/
6-31+G(d,p)/MM potential energy surfaces conrms that
mechanism 2 takes place in a stepwise manner (Fig. S5 and
S6B‡), consisting in the proton abstraction of the alcohol by
D123 residue followed by the hydride transfer from glycerol to
NAD+. This second step, that is the rate-limiting one, renders an
activation free energy (17.1 kcal mol1) that agrees with the
values that can be derived from the experimental rate constants
(16.9 kcal mol1).§ To experimentally conrm themechanism 2,
we constructed the mutant D123N that keeps the hydrogen
bond interactions between glycerol and the amide group of
D123N without affecting the size but precluding the formation
of the alkoxy intermediate, as the amide group is unable to
subtract the proton. D123N mutant indeed abolished the
oxidative activity (Fig. S7‡), which agrees with the analysis of the
geometries derived from classical MD simulations that show no
alternative base in the active site. Hence, we propose the
carboxylate of D123 as the base needed for abstracting the
proton to form the alkoxy intermediate that precedes the
hydride transfer to the nicotinamide cofactor (Fig. 2). For the
rst time, we present both experimental and computational
data that unambiguously unveil the key role of D123 in the
catalytic mechanism of a glycerol dehydrogenase (Fig. 2,
mechanism 2, Fig. S5‡). This residue is highly conserved in
GlyDHs and glycerol 1-phosphate dehydrogenases (Fig. S8 and
S9‡), which supports its important role in the catalytic mecha-
nism. Unlike mannitol dehydrogenases52 (medium chain
dehydrogenases) and short-chain dehydrogenases,50 where Lys
and Tyr residues acts as general base, respectively, BsGlyDH
uses the carboxylate of D123 to subtract the proton from the
secondary alcohol of glycerol.53–56 This conserved residue is not
found in iron-containing polyol dehydrogenases, like 1,2-prop-
anodiol dehydrogenase.57
Once the oxidation mechanism has been elucidated, we
rationally selected three positions to sculpt the active site of
BsGlyDH to better accommodate bulkier glycerol derivatives.
We performed an alanine scanning in the positions V131, Y142
and L252 since they sterically conne the C3 hydroxyl group
within the enzyme binding pocket according to the X-ray
structure (Fig. 1). We also constructed the three possible
combinations of double mutants and the triple one. By replac-
ing these bulkier amino acids by alanine, we were able to
expand the solvent accessible area of the active site up to 108 Å2
(Table S4‡). Nevertheless, there was no correlation between the
size of the binding pocket and the activity towards the glyceryl
ethers (Fig. S10‡). All mutations dramatically reduced the
enzyme activity (<10%) towards the native substrate 1a (glycerol)
except BsGlyDH-V131A (Fig. 3). On the other hand, themutation
Y142A conducted to inactive mutants towards any tested
substrate regardless they were single, double or triple variants.
Pleasantly, the variant BsGlyDH-L252A presented a remarkable
activity towards 1c, even 30% higher than the oxidative activity12014 | Chem. Sci., 2020, 11, 12009–12020of the Wt-GlyDH towards glycerol. For all those active mutants,
we studied their substrate scope using a palette of alkyl/aryl
glyceryl monoethers (Table S1‡). BsGlyDH-L252A was the most
active variant towards all alkylated glycerol derivatives, while
negligible activity was detected for the 1,3-dimethoxy (1b-bis)
and 1,3-diethoxy (1c-bis) glyceryl derivatives. The absence of
activity towards the glyceryl 1,3-dialkylethers agrees with the
fact that GlyDH requires one free primary hydroxyl group to be
coordinated with the catalytic Zn2+. Intriguingly, widening the
active site did not enhance the oxidative activity towards aryl
derivatives. In fact, we found out that both wild-type and the
L252A variant were similarly active towards 1h.
The second best substrate was 1g bearing a 2,2,2-triuorethyl
substituent, which supports that the 22 Å2 larger active site also
possesses the suitable shape to accommodate CH2CF3 moieties
(Table S4‡). Surprisingly, when the aliphatic chain was either
smaller or larger than 2 carbons, the enzyme activity dramati-
cally decayed (Fig. 3). The specic activity results were sup-
ported by kinetic studies (Table 1, Fig. S11 and S12‡), which
additionally demonstrate that shortening the apolar side chain
at position 252 dramatically increases the KM towards glycerol
without signicantly affecting the kcat. In contrast, mutation
L252A signicantly increases (6 times) the BsGlyDH-L252A
catalytic efficiency towards 1c due to the kcat enhancement
(163 times). This variant showed similar trends towards all alkyl
glyceryl derivatives except 1e, for which the kcat was signicantly
lower compared to other substituents (Table 1). BsGlyDH-L252A
presented similar KM values towards NAD
+ under the same
conditions using both glycerol and 1c as substrates, which
indicates that the mutation clearly affects the binding of the
polyol rather than the cofactor (Fig. S13C–F‡). Using glycerol as
substrate at pH 7, we also observed that both wild-type and
mutant enzymes were inhibited by NAD+ at high concentration
(>10 mM) (Fig. S13A–D‡). In the specic case of BsGlyDH-
L252A, inhibition negligibly occurred when using 1c as
substrate under neutral conditions (Fig. S13E and F‡), but it was
noticeable at pH 9 (Fig. S13G and H‡). Remarkably, the catalytic
efficiency of BsGlyDH-L252A was 40 times higher under alkaline
conditions than under pH 7, and its optimal pH was shied 1
unit towards basic values compared to the wild-type enzymeThis journal is © The Royal Society of Chemistry 2020
Table 1 Michaelis–Menten steady-state parameters of Wt-BsGlyDH and BsGlyDH-L25A on different glyceryl ethersa
Substrate




Wt L252A Wt L252A Wt L252A Wt L252A
1a 50  3 1880  80 1.40  0.04 1.70  0.05 7.4  0.2 9.0  0.3 148 5
1b 45  4 977  131 0.160  0.003 1.25  0.06 0.84  0.02 6.6  0.3 19 7
1c 13.4  0.4 371  71 0.036  0.001 6.0  0.5 0.190  0.003 31  3 14 85
1d 30  1 608  102 0.052  0.003 2.2  0.2 0.27  0.02 12  1 9 19
1e n.a 162  24 n.a 0.24  0.02 n.a 1.3  0.1 n.a 8
1f 31.2  0.3 707  77 0.057  0.001 2.4  0.1 0.300  0.001 13  1 10 18
1g 78  8 281  24 0.06  0.02 2.8  0.1 0.32  0.01 14  1 4 51
1h 7  2 n.a 0.14  0.01 n.a 0.7  0.1 n.a 112 n.a
a Activity assay: 1 mM NAD+ in 100 mM sodium phosphate buffer pH 7 at 30 C. n.a: not assessed because it did not reach the substrate saturation.


































































































View Article Online(Fig. S14‡). These kinetics studies reveal an important role of
pH on the glycerol dehydrogenase performance that affects
both binding (overall for the cofactor) and reaction rate
constant.58 Fig. 4, S15 and S16‡ show the free energies proles
and the hydride transfer transition states (named TS2, see
Fig. 2) resulted from QM/MM simulations, for the oxidation
reaction of different substrates catalysed by either theWt-BsGlyDH
or the BsGlyDH-L252A mutant. Energy barriers follow the same
trend observed for the experimental kinetics shown in Table 1. This
mutant presents an energy barrier of 16.2 and 16.5 kcal mol1 for
both 1c (Fig. 4A) and glycerol (Fig. S16‡) oxidations, respectively.
These values are slightly smaller than the barrier previously ob-
tained with the wild-type enzyme using glycerol as substrate
(17.1 kcal mol1) (Fig. S5‡). More interestingly, the free energy
prole of Wt-BsGlyDH shows an energy barrier 2.6 kcal mol1
higher than BsGlyDH-L252A towards the oxidation of 1c under the
same conditions (Fig. 4A), in accordance with the experimental free
energy barriers derived from the kcat values (Tables 1, S5‡). We
suggest that the higher efficiency of engineered BsGlyDH-L252A
results from a less sterically impeded 1c conformation within the
mutated active site, which leads to transition states with lower
energy barriers than within native one. QM/MM MD simulations
revealed weak but stabilizing interactions energies between 1c and
the residues at positions 131, 142 and 252 of BsGlyDH-L252A
during the reactant state. Their synergistic Lennard-Jonnes inter-
actions signicantly contribute to the 1c binding (Fig. S17 and
S18‡). Therefore, the insertion of Ala at position 252 but keeping
the native residues at positions V131 and Y142 seems to optimise
the binding pocket to improve the stability of the transition states
with the ethyl glyceryl monoether. Fig. 4B shows indeed a rotation
(125 degrees) for the CH3- of ethoxy substituent of 1cwithin the less
hindered L252A active site. Similar results were found for the
rational site-directed mutagenesis of a shuffled GlyDH, where the
replacement of one aspartic that clashed with 1,3-butanodiol
enhanced the oxidative activity up to 2.6 times compared to the
wild-type variant.32
The excellent oxidative activity of BsGlyDH-L252A encour-
aged us to carry out the complete bioconversion of 1c and
characterise the resulting product. Since this biotransformation
is NAD+-dependent, we mixed BsGlyDH-L252A with an NADH
oxidase from Thermus thermophilus HB27 (Tt-NOX) and theThis journal is © The Royal Society of Chemistry 2020horse liver catalase (Hl-CAT) in one-pot, aiming at both in situ
recycling the cofactor and removing the H2O2; a toxic by-
product from the recycling system. Using the soluble
enzymes, the reaction roughly reached 25% substrate conver-
sion in 72 hours with enzyme and cofactor total turnover
numbers of 3491 and 13, respectively (Table 2, entry 1). Despite
that low conversion, we characterised the formed product
through 13C and 1H NMR (Fig. S19–S22‡), and mass spectrom-
etry (Fig. S23–S29‡). The analyses conrm that BsGlyDH-L252A
oxidises the C2 of 1c as the wild-type GlyDH does for the glyc-
erol. Remarkably, we did not detect the formation of the alde-
hyde, which indicates that the mutation at the active site alters
the substrate specicity but not the enzyme regioselectivity.
Although product yields were signicantly lower than those
ones obtained through chemical methods,59 the regioselectivity
of this variant towards the C2 of the alkylglyceryl substrate thus
enables the synthesis of the corresponding 3-alkoxy-1-
hydroxyacetones under mild conditions using water as
solvent. More importantly, the enzymatic route smoothly runs
without protection/deprotection steps under acidic conditions
that would provoke the decomposition of the product to methyl
glyoxal, substantially decreasing the isolated yields.59Biotransformation of alkyl/aryl glyceryl ethers using
immobilised GlyDH-L252A
In order to intensify the process and walk towards higher yields,
we immobilised BsGlyDH-L252A on agarose porous microbeads
activated with cobalt-chelates (AG-Co2+) to enhance its operational
stability and increase the biocatalyst volumetric activity. Further-
more, the use of the immobilised enzyme will ease the product
recovery and enable the enzyme reutilization once the reaction is
completed. Since all BsGlyDH variants used in this work were
tagged with 6 His polypeptide at their N-terminus for purica-
tion purposes, we harnessed that tag to site-selectively immobilise
the BsGlyDH-L252A on AG-Co2+. This variant was quantitatively
immobilised on this carrier; however, the specic activity of the
immobilised enzyme was reduced to 19% compared to its free
counterpart under colorimetric assay conditions (Table S6‡). The
immobilised BsGlyDH-L252A performed the selective oxidation of
1c with a TOF 2.4-fold higher than the soluble enzyme, reaching
amaximum yield of 50% aer 72 h under batch conditions (TableChem. Sci., 2020, 11, 12009–12020 | 12015
Fig. 4 (A) Free energy profiles (M06-2X/6-31+G(d,p):PM3/MM PMFs +
ZPE correction) following mechanism 2 for the S-1c oxidation cata-
lysed by Wt-BsGlyDH (dashed orange line) and BsGlyDH-L252A (solid
green line), and of R-1c oxidation catalysed by BsGlyDH-L252A (solid
purple line). (B) Overlapped snapshot of the hydride transfer transition
states (TS2) located in the oxidation of S-1c catalysed by the Wt-
BsGlyDH (orange) and BsGlyDH-L252A (green). NAD+ bound to the
complex of Wt and L252A mutant was coloured in orange and yellow,
respectively. (C) Overlapped snapshots of the hydride transfer transi-
tion state (TS2) located in the oxidation of S-1c (green) and R-1c
(purple) by BsGlyDH-L252A. NAD+ bound to the complex with S and R
isomers was coloured in yellow and pale green, respectively.


































































































View Article Online2, entry 2). This heterogeneous biocatalyst enabled an enzyme and
cofactor total turnover numbers of 64  103 and 25, respectively,
under the studied conditions.12016 | Chem. Sci., 2020, 11, 12009–12020These data demonstrate that immobilised BsGlyDH-L252A
mixed with soluble Tt-NOX and Hl-CAT outperforms the
system with the three soluble enzymes. The apparent lower
activity of the immobilised enzyme seems to be compensated by
its higher robustness under operational conditions.60 The
immobilization of BsGlyDH-L252A allowed us increasing 8
times the volumetric activity of the heterogeneous biocatalyst,
reaching 50% conversion in only 24 h (Table 2, entry 3).
From the reaction time courses, we observed how the
oxidation reaction slows down when the conversion approaches
to 50% (Fig. 5A). Since we used 25 mM racemic mixture of 1c,
that asymptotic behavior points out that BsGlyDH-L252A is
extraordinarily selective for one of the two enantiomers. To
unveil the enantioselectivity of this variant, we performed
further QM/MM computational studies on the two isomers of
1c. The free energy barriers for the oxidation of S-1c
(16.16 kcal mol1) was signicantly lower than that for the R-
enantiomer (44.40 kcal mol1) (Fig. 4A), indicating that the
engineered BsGlyDH variant prefers oxidizing the S-enan-
tiomer. Similar results were observed for the wild-type enzyme
(Fig. S15 and Table S5‡), suggesting that the native active site
also prefers the S-conguration of the substrate for the hydride
transfer to the NAD+. Fig. 4C illustrates an unproductive posi-
tion of R-1c as the secondary alcohol loses its coordination with
the catalytic Zn2+. The same predicted enantiopreference for
both engineered and native variants suggests that the L252A
mutation aids the accommodation of larger glycerol-like
substrates without affecting the regio- and stereoselectivity of
the enzyme. This S-enantiopreference of BsGlyDH agrees with
the enantioselectivity reported for archeal glycerol-1-phosphate
dehydrogenase,61 suggesting a pro-R position of the NAD+
within the active site. GlyDHs from Enterobacter aerogenes and
from Cellulomonas sp. selectively oxidise the R-isomer of 1,2-
diols, kinetically resolving the corresponding S-enantiomers of
phenylglycol (ee 99%, conv. 50%)58 and 1,2-propanodiol (ee
36%, conv. 26%),49 respectively. The opposite CIP priority
between 1c and non alkoxylated 1,2-diols indicates that the
diols are similarly coordinated and positioned within the
enzyme active sites of those GlyDHs, and the hydride from the
substrates is also transferred to Re-face of the NAD+. Embold-
ened by these computational insights, we challenged the
immobilised BsGlyDH-L252A for the kinetic resolution of rac-1h
(Figs. S29–S33‡). Fig. 5B shows that the reaction time course
follows the classical kinetic resolution pattern where the S-
enantiomer is fully oxidised to 3-phenoxy-1-hydroxyacetone,
while the R-enantiomer remains nonreactive (Fig. S33‡). This
result conrms the computational studies and thus demon-
strates that BsGlyDH-L252A is an S-stereoselective
polyol dehydrogenase, enriching the reaction crudes with R-1h
(ee > 99%) aer 72 hours. Since we exploited BsGlyDHA-L252A
to selectively oxidise alkyl and aryl glyceryl monoethers, we
are able to readily prepare the pure R-enantiomer of glycerol
monoethers in one-pot under mild conditions. To the best of
our knowledge, the only reported biotransformations able to
produce this enantiomer is based on asymmetric reduction of
hydroxyacetone monoethers through whole cells of different
yeasts, but with signicantly lower enantiopurity (ee ¼ 73–This journal is © The Royal Society of Chemistry 2020
Table 2 Oxidation of 1c catalysed by soluble and immobilised BsGlyDH-L252A
Entry Biocatalyst Load (mg) Conv./time (%)/(h) TOFc (h1) TTNenzyme
d TTNNAD
+e
1 Soluble 0.24a 25 (72) 617 25 000 13
2 AG-Co2+ 0.186a 50 (72) 1433 64 000 25
3 1.48b 50 (24) 68 1600 25
a Reaction conditions; 18 mU of GlyDH-L252A (soluble or immobilised), 90 mU of soluble Tt-NOX and 4480 mU of soluble Hl-CAT mixed with
1.5 mL of 50 mM of rac-1c, 1 mM NAD+, 150 mM FAD+ in 100 mM sodium phosphate buffer at pH 7 at 30 C. b Reaction conditions; 144 mU of
immobilised GlyDH-L252A, 720 mU of Tt-NOX and 36 000 mU of Hl-CAT CAT mixed with 0.3 mL of 50 mM rac-1c, 1 mM NAD+, 150 mM FAD+ in
100 mM sodium phosphate buffer at pH 7 at 30 C. c Turnover frequency (TOF) was calculated as mmol of product per mmol of enzyme in 24
hours. d TTNenzyme was calculated as mmol of product per mmol of enzyme.
e TTNNAD+ was calculated as mmol of product per mmol of cofactor.
Fig. 5 Time courses of the selective oxidation of rac-1c (A) and rac-1h (B) using BsGlyDH-L252A immobilised on AG-Co2+. For rac-1c, 144mUof
immobilised GlyDH-L252A, 720mUof Tt-NOX and 36 000mUof Hl-CATmixedwith 0.3mL of 25–100mM substrate, 1 mMNAD+, 150 mMFAD+
in 100 mM sodium phosphate buffer at pH 7 at 30 C. For rac-1h, 8.8 U of immobilised GlyDH-L252A were mixed with 1 mL of 2 mM substrate,
4 mM NAD+ in 100 mM sodium phosphate buffer at pH 7 at 30 C.


































































































View Article Online88%).62 Beside the substrate specicity and exquisite enantio-
selectivity of BsGlyDH-L252A, its immobilization on solid
carriers enables to reutilise this biocatalyst in consecutives
operational cycles. Fig. 6 shows that the immobilised enzyme
retains its activity during 6 operational cycles (a total of 6 days of
operation). Glycerol dehydrogenases have been immobilised on
a plethora of carriers through a variety of chemistries to sta-
bilise them for further applications (mainly in the eld of
biosensors).63 Recently, Xu et al. co-aggregated and cross-linked
a wild-type glycerol dehydrogenase together with a NADH
oxidase (enzyme sources were not reported) for the trans-
formation of glycerol into dihydroxyacetone.64 This system was
able to produce up to 10 mM of product and proven reusable for
10 cycles maintaining 60% of its initial activity. In this work, we
achieved up to 33 mM of 3-ethoxy-1-hydroxyacetone using
100 mM of substrate, yet the conversion was limited to 33%. A
lower conversion than 50% suggests product inhibition issues,
only manifested when using high substrate concentrations (>25
mM). In fact, BsGlyDH-L252A underwent a 50% activity
decreasing when incubated at 100 mM dihydroxyacetone
(Fig. S34‡), suggesting that BsGlyDH-L252 is also inhibited by
hydroxyketones. Remarkably, the oxidation of rac-1c catalysed
by the single mutant was inhibited by the ketone to a much
lower extent than the glycerol oxidation performed by the wild-
type enzyme. These results are aligned with other selective bio-This journal is © The Royal Society of Chemistry 2020oxidation catalysed by GlyDHs that also suffer inhibition
issues.49,65 Such product inhibition can be suppressed through
continuous product extraction to complete the kinetic resolu-
tions at high substrate concentrations.65 According to these
results, the application of immobilised GlyDH to the kinetic
resolution of the alkyl glyceryl monoethers and the synthesis of
3-alkoxy-1-hydroxyacetone is one of the few examples in applied
biocatalysis that use polyol dehydrogenases beyond the
production of dihydroxyacetone. Nevertheless, this heteroge-
neous biocatalyst needs to be further optimised in order to
overcome inhibition issues and increase its operational
stability.
One-pot sequential chemo-enzymatic synthesis of 3-ethoxy-1-
hydroxyacetone starting from ethanol and glycidol
To advance in the biorenery concept, we addressed the
synthesis of 3-ethoxy-1-hydroxyacetone using ethanol and
racemic glycidol as raw materials (Scheme 1C). To that aim, we
prepared a bi-functional heterogeneous biocatalyst through the
selective co-immobilization of His-tagged GlyDH-L252A and the
water-forming NAD+ oxidase from Lactobacillus pentosus (Lp-
NOX) on AG-Co2+ porous microbeads. We swapped Tt-NOX by
Lp-NOX, because the latter is a water-forming oxidase which
makes unnecessary the use of CAT for the in situ removal of
H2O2, simplifying the overall process. Furthermore, co-Chem. Sci., 2020, 11, 12009–12020 | 12017
Fig. 6 Recycling of heterogeneous biocatalyst BsGlyDH-L252A
immobilised on AG-Co2+ (144 mU, 100 mg biocatalyst). Reaction
mixture consisted in 300 mL of 25 mM of rac-1c, 1 mM NAD+, 150 mM
FAD+, 720 mU of soluble Tt-NOX and 36 000mU of soluble Hl-CAT in
100 mM sodium phosphate buffer at pH 7 at 30 C. Each cycle
corresponds to 24 h at the described conditions.


































































































View Article Onlineimmobilised LpNOX allowed 14% higher conversion during the
oxidation of 1c, using 2.2 times lower biocatalyst load (16%
mass load including the carrier) than using the pair TtNOX/CAT
immobilized on agarose porous beads functionalized with
aldehyde groups (36% mass load) (Fig. S35‡).
Firstly, we performed the alcoholysis of glycidol with an excess
of ethanol and using KOH as basic catalyst.18 Aer the chemical
step and using the same pot, the reaction crude was neutralised,
cooled down to 25 C and properlymixed with the reactionmixture
(1mMNAD+, 150 mMFAD+ in 100mM sodium phosphate buffer at
pH 8), diluting the substrate concentration to 20 mM. Finally, the
bi-enzyme heterogeneous biocatalyst was directly added to the
reaction crude to trigger the sequential enzymatic step. Fig. 7Fig. 7 Chemo-enzymatic synthesis of 3-alkoxy-1-hydroxyacetone.
Heterogeneous biocatalyst GlyDH-L252A co-immobilised with Lp-
NOX on AG-Co2+ (100 mg biocatalyst). For the enzymatic step, the
reaction mixture consisted in 500 mL of 20 mM of substrate (pure, raw
from chemo synthesis with ethanol and raw from chemo synthesis
without ethanol), 1 mM NAD+, 150 mM FAD+ in 100 mM sodium
phosphate buffer at pH 8 at 30 C.
12018 | Chem. Sci., 2020, 11, 12009–12020shows that the diluted and neutralised crude coming from the
chemical reaction can be readily used for the enzymatic selective
oxidation without affecting the reaction efficiency. In all the cases,
we obtained similar conversions, even in presence of the excess of
ethanol needed for the chemical alcoholysis. This batch system
was scaled up to 50mL (120mg of 1c) of reactionmixture reaching
similar conversion (Fig. S36‡). Although desired, a concurrent
process is impeded due to the basic conditions demanded by the
epoxide ring opening that completely inactivates the enzymes
participating in the selective oxidation. However, we herein
demonstrate that the sequential chemo-enzymatic cascade in one-
pot successfully works without any purication step. The
alcoholysis/selective oxidation (kinetic resolution) herein pre-
sented, contributes to expand the repertoire of chemo-enzymatic
processes for manufacturing of enantiomerically pure secondary
alcohols as pharmaceutical66,67 and polymer building blocks.68–70
Conclusions
In this work, we have deciphered the oxidative catalytic mech-
anism of a GlyDH from Bacillus stearothermophilus towards
polyols substrates through QM/MM molecular dynamics
simulations. Our results show how the reaction takes place by
means of a stepwise mechanism that consists in a proton
transfer from the hydroxyl group of C2 atom of the alcohol to
D123 residue to form the alkoxide intermediate followed by the
hydride transfer from C2 atom of the alcohol to NAD+. Based on
these mechanistic insights, we rationally engineered the
BsGlyDH to regio- and enatioselectively oxidise glycerol mono-
ethers. We found that a single mutation in its active site (L252A)
provides enough space to accommodate bulkier glycerol deriv-
atives in productive congurations. This variant was able to
selectively oxidise a battery of glyceryl monoethers with
different alkyl/aryl substituents. Besides the activity towards
these substrates, we also report the exquisite enantiopreference
of BsGlyDH towards S-isomers of substituted glycerol deriva-
tives. Aer being immobilised on porous carriers, the best
engineered variant serves as an efficient heterogeneous bio-
catalyst for the kinetic resolution of glyceryl monoethers and
the production of the 3-alkoxy-1-hydroxyacetones. Herein, we
have also contributed to enlarge the toolbox of the one-pot
chemo-enzymatic processes through coupling the base-
catalysed ethanolysis of glycidol with the enzymatic selective
oxidation of 3-ethoxy-propan-1,2-diol in a sequential mode. All
the results presented here support an interdisciplinary path
that goes from the molecular design of enzymes to the process
engineering and development for the manufacturing of prod-
ucts, like 3-alkoxy-1-hydroxyacetones. These compounds have
been synthesised before neither through biocatalytic methods
nor following a one-pot sequential reaction starting from bio-
based materials (ethanol and glycidol). So far, the kinetic
resolution of these glycerol derivatives has an impact in applied
biocatalysis, but moving this system towards dynamic kinetic
resolution to achieve 100% yield is a future challenge.
Furthermore, we foresee that new engineering campaigns will
expand the GlyDH substrate scope and change its enantiopre-
ference. Likewise, the immobilization of GlyDH must beThis journal is © The Royal Society of Chemistry 2020


































































































View Article Onlineoptimised to further increase the operational stability of this
heterogeneous biocatalyst.Conflicts of interest
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